Literature DB >> 29421589

A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder.

Ryan W Y Lee1, Michael J Corley2, Alina Pang3, Gaye Arakaki4, Lisa Abbott5, Michael Nishimoto6, Rob Miyamoto7, Erica Lee8, Susan Yamamoto9, Alika K Maunakea10, Annette Lum-Jones11, Miki Wong12.   

Abstract

Entities:  

Keywords:  Autism; High fat; Intervention; Ketogenic diet; Neurodevelopment; Therapy

Mesh：

Substances：

Year:  2018        PMID： 29421589      PMCID： PMC5863039          DOI： 10.1016/j.physbeh.2018.02.006

Source DB:  PubMed          Journal:  Physiol Behav        ISSN： 0031-9384


× No keyword cloud information.
  43 in total

1.  Metabolic approaches to the treatment of autism spectrum disorders.

Authors:  T Page
Journal:  J Autism Dev Disord       Date:  2000-10

Review 2.  Toward an immune-mediated subtype of autism spectrum disorder.

Authors:  Christopher J McDougle; Samantha M Landino; Arshya Vahabzadeh; Julia O'Rourke; Nicole R Zurcher; Beate C Finger; Michelle L Palumbo; Jessica Helt; Jennifer E Mullett; Jacob M Hooker; William A Carlezon
Journal:  Brain Res       Date:  2014-11-13       Impact factor: 3.252

3.  The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid.

Authors:  Kamila Castro; Diego Baronio; Ingrid Schweigert Perry; Rudimar Dos Santos Riesgo; Carmem Gottfried
Journal:  Nutr Neurosci       Date:  2016-02-08       Impact factor: 4.994

4.  Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

Authors:  Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Isaac Pessah; Judy Van de Water
Journal:  Brain Behav Immun       Date:  2010-08-10       Impact factor: 7.217

5.  Ketogenic diet exhibits anti-inflammatory properties.

Authors:  Nina Dupuis; Niccolo Curatolo; Jean-François Benoist; Stéphane Auvin
Journal:  Epilepsia       Date:  2015-05-23       Impact factor: 5.864

Review 6.  Ketone bodies as signaling metabolites.

Authors:  John C Newman; Eric Verdin
Journal:  Trends Endocrinol Metab       Date:  2013-10-18       Impact factor: 12.015

7.  Levels of High-Density Lipoprotein Cholesterol are Associated With Biomarkers of Inflammation in Patients With Acute Coronary Syndrome.

Authors:  Héctor González-Pacheco; Luis M Amezcua-Guerra; Armando Vazquez-Rangel; Carlos Martínez-Sánchez; Oscar Pérez-Méndez; Juan Verdejo; Rafael Bojalil
Journal:  Am J Cardiol       Date:  2015-09-10       Impact factor: 2.778

8.  Evidence for treatable inborn errors of metabolism in a cohort of 187 Greek patients with autism spectrum disorder (ASD).

Authors:  Martha Spilioti; Athanasios E Evangeliou; Despoina Tramma; Zoe Theodoridou; Spyridon Metaxas; Eleni Michailidi; Eleni Bonti; Helen Frysira; A Haidopoulou; Despoina Asprangathou; Aggelos J Tsalkidis; Panagiotis Kardaras; Ron A Wevers; Cornelis Jakobs; K Michael Gibson
Journal:  Front Hum Neurosci       Date:  2013-12-24       Impact factor: 3.169

9.  Ketogenic diets improve behaviors associated with autism spectrum disorder in a sex-specific manner in the EL mouse.

Authors:  David N Ruskin; Jessica A Fortin; Subrina N Bisnauth; Susan A Masino
Journal:  Physiol Behav       Date:  2016-11-09

10.  Elevated maternal C-reactive protein and autism in a national birth cohort.

Authors:  A S Brown; A Sourander; S Hinkka-Yli-Salomäki; I W McKeague; J Sundvall; H-M Surcel
Journal:  Mol Psychiatry       Date:  2013-01-22       Impact factor: 15.992
View more
  21 in total

Review 1.  Are therapeutic diets an emerging additional choice in autism spectrum disorder management?

Authors:  M Gogou; G Kolios
Journal:  World J Pediatr       Date:  2018-05-30       Impact factor: 2.764

2.  Social-like responses are inducible in asocial Mexican cavefish despite the exhibition of strong repetitive behavior.

Authors:  Motoko Iwashita; Masato Yoshizawa
Journal:  Elife       Date:  2021-09-20       Impact factor: 8.140

3.  Rescue of histone hypoacetylation and social deficits by ketogenic diet in a Shank3 mouse model of autism.

Authors:  Luye Qin; Kaijie Ma; Zhen Yan
Journal:  Neuropsychopharmacology       Date:  2021-10-26       Impact factor: 8.294

Review 4.  Intergenerational Metabolic Syndrome and Neuronal Network Hyperexcitability in Autism.

Authors:  Aileen Rivell; Mark P Mattson
Journal:  Trends Neurosci       Date:  2019-09-05       Impact factor: 13.837

5.  Preclinical testing of the ketogenic diet in fragile X mice.

Authors:  Pamela R Westmark; Alejandra Gutierrez; Aaron K Gholston; Taralyn M Wilmer; Cara J Westmark
Journal:  Neurochem Int       Date:  2020-01-17       Impact factor: 3.921

Review 6.  Importance of lipids for upper motor neuron health and disease.

Authors:  Aksu Gunay; Heather H Shin; Oge Gozutok; Mukesh Gautam; P Hande Ozdinler
Journal:  Semin Cell Dev Biol       Date:  2020-12-13       Impact factor: 7.727

7.  The use of the ketogenic diet in the treatment of psychiatric disorders.

Authors:  Erika E Tillery; Katie D Ellis; Tiffaney B Threatt; Hannah A Reyes; Christopher S Plummer; Logan R Barney
Journal:  Ment Health Clin       Date:  2021-05-12

8.  Electrical Control in Neurons by the Ketogenic Diet.

Authors:  Nagisa Sada; Tsuyoshi Inoue
Journal:  Front Cell Neurosci       Date:  2018-07-16       Impact factor: 5.505

Review 9.  Ketogenic Dietary Therapies in Patients with Autism Spectrum Disorder: Facts or Fads? A Scoping Review and a Proposal for a Shared Protocol.

Authors:  Costanza Varesio; Serena Grumi; Martina Paola Zanaboni; Martina Maria Mensi; Matteo Chiappedi; Ludovica Pasca; Cinzia Ferraris; Anna Tagliabue; Renato Borgatti; Valentina De Giorgis
Journal:  Nutrients       Date:  2021-06-16       Impact factor: 5.717

10.  Ketogenic Diet Provided During Three Months Increases KCC2 Expression but Not NKCC1 in the Rat Dentate Gyrus.

Authors:  Leticia Granados-Rojas; Karina Jerónimo-Cruz; Tarsila Elizabeth Juárez-Zepeda; Miguel Tapia-Rodríguez; Armando R Tovar; Rodolfo Rodríguez-Jurado; Liliana Carmona-Aparicio; Noemí Cárdenas-Rodríguez; Elvia Coballase-Urrutia; Matilde Ruíz-García; Pilar Durán
Journal:  Front Neurosci       Date:  2020-07-07       Impact factor: 4.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.